Zobrazeno 1 - 10
of 647
pro vyhledávání: '"Long-acting injectable antipsychotics"'
Autor:
Rachael C. Davis, BS, Jianing Xu, MS, Daniel B. Hall, PhD, Xianyan Chen, PhD, Michaelyn M. Moretz, Henry N. Young, PhD, Joshua Caballero, PharmD, BCPP, FCCP
Publikováno v:
Mental Health Clinician, Vol 14, Iss 6, Pp 334-338 (2024)
Introduction Single-dose injectable aripiprazole lauroxil (SDIAL) is used with long-acting injectable (LAI) aripiprazole lauroxil in the treatment of schizophrenia. SDIAL can be used to either initiate treatment or supplement during maintenance when
Externí odkaz:
https://doaj.org/article/accf7f91e1704998af70124a0387b86d
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 2227-2235 (2024)
Martha Sajatovic,1 Monica Doring,2 Oliver J Lopena,2 Karen Johnston,2 Ibrahim Turkoz,3 Nia Josiah,4 Camilo Obando2 1University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA; 2Janssen Scient
Externí odkaz:
https://doaj.org/article/de2db74823384aed9e263892cbaa6ede
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1985-1993 (2024)
Bo-Chieh Chang,1 Meng-Hsuan Kuo,1 Chi-Hui Lee,1 Ya-Lan Chu,1 Kuang-Peng Chen,2 Chun-Liong Tung,2 Ya-Hui Yang,3 Chuan-Sheng Hung,4 Jui-Hsiu Tsai,2,5 Hung-Yi Chuang6 1Department of Pharmacy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation,
Externí odkaz:
https://doaj.org/article/af2f34c50d074448a59abcf8434a80c9
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1837-1848 (2024)
Sanghyuk Seo,1 Bridget E Healey,2 Ronae McLin,2 Naomi C Sacks,2 Carmela J Benson,1 Leslie Citrome3 1Medical Affairs Neuroscience, Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Titusville, NJ, USA; 2PRECISIONheor, Boston, MA, USA; 3Dep
Externí odkaz:
https://doaj.org/article/bcd40a22401b44bda3275a7e9af862a3
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 2, Pp 417-423 (2024)
Abstract Aims To investigate the negative attitudes of Japanese psychiatrists toward atypical long‐acting injectable (LAI) antipsychotics, which are the current mainstream LAIs in Japan. Methods We surveyed 69 Japanese psychiatrists using a 5‐poi
Externí odkaz:
https://doaj.org/article/e5e3a299efdd4bc5b7d29bbd5b5d2c47
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 34-41 (2024)
Abstract The coronavirus disease pandemic has presented healthcare systems with unprecedented challenges globally and substantially impacted the management of chronic diseases such as schizophrenia. This narrative review highlights the usefulness of
Externí odkaz:
https://doaj.org/article/8dbdef66b2fd4cc8868b7e068ec8b7d1
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 19, Pp 1987-2006 (2023)
Ning Ma,1– 3,* Lei Zhang,4,* Wufang Zhang,1– 3 Yingying He,1– 3 Chong Ye,4 Xin Li4 1Peking University Sixth Hospital, Beijing, People’s Republic of China; 2Peking University Institute of Mental Health, Beijing, People’s Republic of
Externí odkaz:
https://doaj.org/article/93f0ad18741f49f89c42e7ebdcaa3c87
Autor:
García-Carmona JA, Pappa S
Publikováno v:
Drug, Healthcare and Patient Safety, Vol Volume 15, Pp 113-123 (2023)
Juan Antonio García-Carmona,1– 3 Sofia Pappa4,5 1Department of Neurology, Santa Lucia University Hospital, Cartagena, Murcia, Spain; 2Unit of Acute Psychiatry, Reina Sofía University Hospital, Murcia, Spain; 3Group of Clinical and Experimental Ph
Externí odkaz:
https://doaj.org/article/cd714793108946a89db86905337f077a
Autor:
Caballero Joshua PharmD, BCPP, FCCP, Xu Jianing MS, Hall Daniel B. PhD, Chen Xianyan PhD, Young Henry N. PhD
Publikováno v:
Mental Health Clinician, Vol 13, Iss 4, Pp 183-189 (2023)
Introduction In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study
Externí odkaz:
https://doaj.org/article/95953c0eadaf4dbdbec567925927df5f
Autor:
Piyanut Ueapanjasin, Wiwat Thavornwattanayong, Jadesada Lertsirimunkong, Kamolpat Chaiyakittisopon
Publikováno v:
Siriraj Medical Journal, Vol 75, Iss 10 (2023)
Objective: Long-acting injectable (LAI)-aripiprazole and LAI-paliperidone palmitate are both second-generation antipsychotics that have been introduced to increase drug compliance in patients. These attributes are expected to enhance drug compliance,
Externí odkaz:
https://doaj.org/article/286f6af22cee433eb7910d79c8314aa4